Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir.
Saved in:
| Title: | Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir. |
|---|---|
| Authors: | Tadmor, Tamar1 (AUTHOR), Melamed, Guy2 (AUTHOR), Patalon, Tal2 (AUTHOR), Alapi, Hilel2 (AUTHOR), Rokach, Lior3 (AUTHOR) |
| Source: | Leukemia & Lymphoma. May2023, Vol. 64 Issue 5, p1054-1056. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2023.2183732 |